Renaissance Technologies
NXTM

Renaissance Technologies’s NxStage Medical Inc. NXTM Stock Holding History

Renaissance Technologies’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-332,783
Closed -$9.52M – 3841
2018
Q4 		$9.52M Buy
332,783
+81,500
+32% +$2.32M 0.01% 1337
2018
Q3 		$7.01M Buy
251,283
+91,000
+57% +$2.56M 0.01% 1577
2018
Q2 		$4.47M Sell
160,283
-199,300
-55% -$5.34M ﹤0.01% 1856
2018
Q1 		$8.94M Buy
359,583
+219,683
+157% +$5.34M 0.01% 1439
2017
Q4 		$3.39M Buy
+139,900
New +$3.69M ﹤0.01% 2046
2017
Q3 		– Sell
-14,783
Closed -$371K – 3483
2017
Q2 		$371K Sell
14,783
-132,200
-90% -$3.27M ﹤0.01% 2841
2017
Q1 		$3.94M Buy
146,983
+62,200
+73% +$1.72M 0.01% 1834
2016
Q4 		$2.22M Sell
84,783
-166,200
-66% -$4.11M ﹤0.01% 2168
2016
Q3 		$6.27M Buy
250,983
+92,500
+58% +$2.16M 0.01% 1457
2016
Q2 		$3.44M Sell
158,483
-320,300
-67% -$5.71M 0.01% 1856
2016
Q1 		$7.18M Buy
478,783
+116,793
+32% +$1.96M 0.01% 1361
2015
Q4 		$7.93M Buy
361,990
+66,500
+23% +$1.24M 0.02% 1154
2015
Q3 		$4.66M Buy
+295,490
New +$4.74M 0.01% 1444
2015
Q2 		– Sell
-57,190
Closed -$989K – 3478
2015
Q1 		$989K Sell
57,190
-69,800
-55% -$1.23M ﹤0.01% 2314
2014
Q4 		$2.28M Buy
126,990
+59,390
+88% +$956K 0.01% 1728
2014
Q3 		$888K Buy
+67,600
New +$910K ﹤0.01% 2084
2013
Q4 		– Sell
-69,600
Closed -$916K – 3107
2013
Q3 		$916K Sell
69,600
-62,700
-47% -$822K ﹤0.01% 2052
2013
Q2 		$1.89M Buy
+132,300
New +$1.66M 0.01% 1617

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Renaissance Technologies's NXTM Position: Q1 2019 in Review

Renaissance Technologies sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 332,783 shares — an estimated $9.52M sold.

Renaissance Technologies first reported a position in NXTM in Q2 2013 and held it in 18 quarters. The position peaked at $9.52M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Renaissance Technologies reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Renaissance Technologies sold 332,783 NxStage Medical Inc. shares in Q1 2019, an estimated $9.52M.
  • Renaissance Technologies first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 18 quarters.
  • Renaissance Technologies's NxStage Medical Inc. position peaked at $9.52M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.